Search - tctmd.com

Displaying 21 - 40 of 105

Sort: Relevancy | Date

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

Todd Neale

July 26, 2021

Presentation TVT 2021

PFO Closure in Non-Stroke Patients

Presenter: Brian Whisenant

July 22, 2021

Presentation TVT 2021

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

Presenter: Megan Coylewright

July 22, 2021

Presentation TVT 2021

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

Presenter: Mark Reisman

July 22, 2021

Presentation TVT 2021

Next Generation Stroke Reduction

Presenter: Wayne Batchelor

July 21, 2021

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

Advertisement

3M TAVR: Minimalist TAVI Pathway Saves Money

PFO Closure in Non-Stroke Patients

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

Next Generation Stroke Reduction

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Device Explants After TAVR Rare but Risky

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content